The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: A systematic review

Yun Yin,Pengyue Shen,Haonan Lu,Yuenan Liu,Qingyu Dou,Lin Zhang,Xiangyi Kong,Shujuan Yang,Peng Jia,Kristen E. Rohli
DOI: https://doi.org/10.1016/j.pcd.2021.08.014
IF: 2.567
2021-12-01
Primary Care Diabetes
Abstract:This review comprehensively summarizes epidemiologic evidence of COVID-19 in patients with Type 2 diabetes, explores pathophysiological mechanisms, and integrates recommendations and guidelines for patient management. We found that diabetes was a risk factor for diagnosed infection and poor prognosis of COVID-19. Patients with diabetes may be more susceptible to adverse outcomes associated with SARS-CoV-2 infection due to impaired immune function and possible upregulation of enzymes that mediate viral invasion. The chronic inflammation caused by diabetes, coupled with the acute inflammatory reaction caused by SARS-CoV-2, results in a propensity for inflammatory storm. Patients with diabetes should be aware of their increased risk for COVID-19.
endocrinology & metabolism,primary health care
What problem does this paper attempt to address?